![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Martin-Liberal Juan Lagares-Tena Laura Larkin James
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.13, Iss.4, 2014-04, pp. : 483-495
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By McCubrey James A Steelman Linda S Abrams Steven L Chappell William H Russo Suzanne Ove Roger Milella Michele Tafuri Agostino Lunghi Paolo Bonati Antonio Stivala Franca Nicoletti Ferdinando Libra Massimo Martelli Alberto M Montalto Giuseppe Cervello Melchiorre
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
RAS/RAF/MEK Inhibitors in Oncology
Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. :